Literature DB >> 16815847

Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2.

Lu Chen1, Brian M Necela, Weidong Su, Masahiro Yanagisawa, Panos Z Anastasiadis, Alan P Fields, E Aubrey Thompson.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) causes epithelial to mesenchymal transformation (EMT) in intestinal epithelial cells, as evidenced by reorganization of the actin cytoskeleton, acquisition of a polarized, mesenchymal cellular morphology, increased cellular motility, and colony scattering. This response is due to activation of Cdc42, resulting in p21-activated kinase-dependent phosphorylation and activation of MEK1 Ser(298) and activation of ERK1/2. Dominant negative MEK1, MEK2, and ERK2 block PPARgamma-induced EMT, whereas constitutively active MEK1 and MEK2 induce a mesenchymal phenotype similar to that evoked by PPARgamma. PPARgamma also stimulates ERK1/2 phosphorylation in the intestinal epithelium in vivo. PPARgamma induces the p110alpha subunit of phosphoinositide 3-kinase (PI3K), and inhibition of PI3K blocks PPARgamma-dependent phosphorylation of MEK1 Ser(298), activation of ERK1/2, and EMT. We conclude that PPARgamma regulates the motility of intestinal epithelial cells through a mitogen-activated protein kinase cascade that involves PI3K, Cdc42, p21-activated kinase, MEK1, and ERK1/2. Regulation of cellular motility through Rho family GTPases has not been previously reported for nuclear receptors, and elucidation of the mechanism that accounts for the role of PPARgamma in regulating motility of intestinal epithelial cells provides fundamental new insight into the function of this receptor during renewal of the intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815847     DOI: 10.1074/jbc.M604147200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Differentiation of human mesenchymal stem cells on plasma-treated polyetheretherketone.

Authors:  Jasmin Waser-Althaus; Achim Salamon; Marcus Waser; Celestino Padeste; Michael Kreutzer; Uwe Pieles; Bert Müller; Kirsten Peters
Journal:  J Mater Sci Mater Med       Date:  2013-11-08       Impact factor: 3.896

2.  Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.

Authors:  Maria Rita Milone; Biagio Pucci; Tommaso Colangelo; Rita Lombardi; Federica Iannelli; Vittorio Colantuoni; Lina Sabatino; Alfredo Budillon
Journal:  Mol Oncol       Date:  2016-07-25       Impact factor: 6.603

3.  Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension.

Authors:  Lili Zhang; Peng Xie; Jingzhou Wang; Qingwu Yang; Chuanqin Fang; Shuang Zhou; Jingcheng Li
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

Review 4.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

5.  A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons.

Authors:  John Dill; Ankur R Patel; Xiao-Li Yang; Robert Bachoo; Craig M Powell; Shuxin Li
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

6.  Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma.

Authors:  Nicholas P Evans; Sarah A Misyak; Eva M Schmelz; Amir J Guri; Raquel Hontecillas; Josep Bassaganya-Riera
Journal:  J Nutr       Date:  2010-01-20       Impact factor: 4.798

7.  Molecular predictors of 3D morphogenesis by breast cancer cell lines in 3D culture.

Authors:  Ju Han; Hang Chang; Orsi Giricz; Genee Y Lee; Frederick L Baehner; Joe W Gray; Mina J Bissell; Paraic A Kenny; Bahram Parvin
Journal:  PLoS Comput Biol       Date:  2010-02-26       Impact factor: 4.475

8.  Effects of PPAR gamma ligands on TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells.

Authors:  Xiahui Tan; Hayat Dagher; Craig A Hutton; Jane E Bourke
Journal:  Respir Res       Date:  2010-02-23

9.  Peroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1.

Authors:  Brian M Necela; Weidong Su; E Aubrey Thompson
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

10.  Current understanding of the role of PPARγ in gastrointestinal cancers.

Authors:  Bing Zou; Liang Qiao; Benjamin C Y Wong
Journal:  PPAR Res       Date:  2009-10-26       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.